High-throughput quantitative microscopy-based half-life measurements of intravenously injected agents
- 3 February 2020
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (7) , 3502-3508
Abstract
Many eubacteria are resistant to the toxic oxidizing agent potassium tellurite, and tellurite resistance involves diverse biochemical mechanisms. Expression of the iscS gene from Geobacillus stearothermophilus V, which is naturally resistant to tellurite, confers tellurite resistance in Escherichia coli K-12, which is naturally sensitive to tellurite. The G. stearothermophilus iscS gene encodes a cysteine desulfurase. A site-directed mutation in iscS that prevents binding of its pyridoxal phosphate cofactor abolishes both enzyme activity and its ability to confer tellurite resistance in E. coli. Expression of the G. stearothermophilus iscS gene confers tellurite resistance in tellurite-hypersensitive E. coli iscS and sodA sodB mutants (deficient in superoxide dismutase) and complements the auxotrophic requirement of an E. coli iscS mutant for thiamine but not for nicotinic acid. These and other results support the hypothesis that the reduction of tellurite generates superoxide anions and that the primary targets of superoxide damage in E. coli are enzymes with iron-sulfur clusters.Keywords
Funding Information
- HHS | NIH | NIH Office of the Director (UG3 HL147352)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (U01 AI132895)
- HHS | NIH | National Heart, Lung, and Blood Institute (R01 HL125892)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK101019)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK007276)
- HHS | NIH | National Institute of General Medical Sciences (T32 GM86287)
- HHS | NIH | National Heart, Lung, and Blood Institute (F32 HL142144)
This publication has 24 references indexed in Scilit:
- Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effectInternational Journal of Nanomedicine, 2014
- The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticlesBiomaterials, 2014
- PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGSJournal of Visualized Experiments, 2013
- Short-chain PEG molecules strongly bound to magnetic nanoparticle for MRI long circulating agentsActa Biomaterialia, 2013
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological ProfileScience Translational Medicine, 2012
- A Nanoparticle Size Series for In Vivo Fluorescence ImagingAngewandte Chemie International Edition, 2010
- In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging AgentBioconjugate Chemistry, 2010
- Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriersJournal of Controlled Release, 1995
- Biodegradable Long-Circulating Polymeric NanospheresScience, 1994
- Biological Effects of Blood Loss: Implications for Sampling Volumes and Techniques * Commentary: H. Richard AdamsILAR Journal, 1989